ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novatek Seeks EUA for TQ Formula to Treat COVID
November 02, 2021Novatek Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company, announced topline results from a Phase 2 randomized, controlled multicenter trial... -
Novatek seeks FDA authorisation for oral drug to treat Covid-19
November 02, 2021Novatek Pharmaceuticals has sought emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its oral TQ Formula to treat Covid-19-infected individuals in the outpatient setting. -
Novatek seeks EUA after its Oral TQ Formula Significantly improved Total Symptom Burden in a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of COVID-19 Patients in the Outpatient Setting
November 02, 2021Novatek Pharmaceuticals, Inc. ("Novatek") a privately held, clinical-stage biopharmaceutical company today announced topline results from a Phase 2 randomized, controlled multicenter trial (BOSS-Covid-19 study)... -
Novatek Requalified as Supplier for Boehringer Aseptic Mfg. Facilities
May 27, 2021Novatek's regulatory compliant quality solutions used at Boehringer for human pharma, animal health and biopharmaceutical sterile manufacturing sites.
Pharma Sources Insight January 2025
